ESMO: European Society for Medical Oncology

  1. New eUpdate featuring ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) Grading and Treatment Recommendation for Thyroid Cancer
  2. Approval is based on findings from the SPARTAN study
  3. Activating T cells in tumours eliminated even distant tumour sites in mouse cancer models
  4. Atezolizumab and bevacizumab doublet in first-line treatment for patients with advanced or metastatic RCC whose disease express the PD-L1
  5. US medical community will now have a domestic source of Tc-99m through the use of the system that marks the first non-uranium process for the production of Mo-99 to prepare the Tc-99m